The risk of chronic diseases and congenital malformations during childhood and adolescence after in utero exposure to thiopurines,Alimentary Pharmacology & Therapeutics

当前位置： X-MOL 学术 › Aliment. Pharm. Ther. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

The risk of chronic diseases and congenital malformations during childhood and adolescence after in utero exposure to thiopurines
Alimentary Pharmacology & Therapeutics ( IF 6.6 ) Pub Date : 2021-08-31 , DOI: 10.1111/apt.16578
Line Riis Jølving _{1,

2} , Pavithra Laxsen Anru ₁ , Jan Nielsen _{1,

2} , Sonia Friedman _{2,

3} , Bente Mertz Nørgård _{1,

2,

3}

Affiliation

Women with autoimmune diseases, particularly inflammatory bowel disease (IBD), often need to continue immunomodulatory therapies during pregnancy. While the evidence of birth and short-term outcomes in children exposed in utero to these medicines is reassuring, long-term safety data are lacking.

中文翻译：